Democratic Party lawmaker Kang Ho-won claimed on the 31st, “Even though candidate Kim received a Sejong apartment as a special supply, he did ‘government finance’, such as living in an office in Osong, Sejong for free while serving as deputy director and deputy director of the Ministry of Food and Drug Safety.”
According to Rep. Kang, when candidate Kim served as the deputy director of the Ministry of Food and Drug Safety in 2012 (then the Food and Drug Administration), he received an 84-square-meter apartment ‘Sejong Hillstate’ the same size as the residence as a special supply (special task) for Sejong city officials.
Kang’s office is that candidate Kim lived in the residence given to the deputy director of the Food and Drug Administration at the time and paid only 250,000 won per month in the name of administrative expenses.
Regarding this, candidate Kim said, “As I retired from public service and became a member of the National Assembly, I sold it in 2017 because there was no reason to live there. he explained
However, Rep. Kang pointed out that, although candidate Kim said that he had received an apartment for the purpose of real residence, it was revealed that he had lived in an official residence and that he had made a ‘false explanation’.
Rep. Kang said, “The fact that I applied for a special supply of public officials while living in a residence operated by national taxes is a typical ‘government finance technique’ for the purpose of pursuing private interests. The explanation was revealed to be a lie within a day.”
Candidate Kim received Hillstate as a special supply (special attack) for public officials in Sejong City in 2012 and sold it in 2017, earning more than 100 million won in profit.
Democratic Party lawmaker Choi Jong-yoon also raised suspicions that candidate Kim received rebates from four pharmaceutical companies and one wholesaler while he was deputy head of the Ministry of Food and Drug Safety. He said that he did not inform the Ministry of Health and Welfare, the disposition agency, of 6.95 billion won in rebates from four pharmaceutical companies and one wholesaler.
Rep. Choi said, “The Ministry of Food and Drug Safety’s Central Investigation Team on Rebates was directly under the Deputy Director, but it did not notify the Ministry of Health and Welfare, the agency that disposes of the findings, and was pointed out by the Board of Audit and Inspection. .